CatalystFDA/Bio

SIONNA THERAPEUTICS, INC. (SION) DISCUSSES CLINICAL TRIAL RESULTS AND DISCONTINUATION OF 719 PROGRAM IN CYSTIC FIBROSIS TRANSCRIPT - SEEKINGALPHA

Clinical trial results plus discontinuation of 719 program signal material pipeline shift.

What changed

Clinical trial results plus discontinuation of 719 program signal material pipeline shift.

Why it matters

Clinical trial results plus discontinuation of 719 program signal material pipeline shift. — impact context not separately stored; see What changed.

Sources